Willett, Julian Daniel Sunday
Lu, Tianyuan
Nakanishi, Tomoko
Yoshiji, Satoshi
Butler-Laporte, Guillaume
Zhou, Sirui
Farjoun, Yossi
Richards, J. Brent http://orcid.org/0000-0002-3746-9086
Funding for this research was provided by:
Canadian Institutes of Health Research (CIHR: 365825; 409511, 100558, 169303, 476575)
Fonds de Recherche du Québec - Santé
McGill University
Lady Davis Institute for Medical Research
Fondation de l'Hôpital général juif
Canadian Foundation for Innovation
Foundation for the National Institutes of Health
Génome Québec
Public Health Agency of Canada
Article History
Received: 16 October 2022
Accepted: 30 June 2023
First Online: 28 August 2023
Declarations
:
: JBR’s institution has received investigator-initiated grant funding from Eli Lilly, GlaxoSmithKline and Biogen for projects unrelated to this research. He is the CEO of 5 Prime Sciences (ExternalRef removed), which provides research services for biotech, pharma and venture capital companies for projects unrelated to this research.
: Soskic et al. biological samples were ethically sourced and used in research under an institutional review board-approved protocol (Soskic et al. CitationRef removed). BQC19 received ethical approval from the Jewish General Hospital research ethics board (2020–2137) and the Centre Hospitalier de l’Université de Montréal institutional ethics board (MP-02–2020-8929, 19.389). Specimens collected by GTEx were sourced per protocol for an institutional review board (GTEx Consortium CitationRef removed).